![]() |
|
|
Vol. 295, Issue 2, 818-823, November 2000
Consiglio Nazionale delle Ricerche Institute of Clinical Physiology
Laboratory for Thrombosis and Vascular Research, Pisa, Italy
Because nitric oxide (NO) inhibits the expression of endothelial
leukocyte adhesion molecules, NO-generating compounds have major
therapeutic potential for use outside their classical indications. We
report on the in vitro potential antiatherogenicity of two novel
cysteine-containing NO donors, SP/W 3672, a fast spontaneous NO
releaser, and its prodrug SP/W 5186, which liberates NO after bioactivation. The ability of these two compounds to inhibit monocyte adhesion and surface expression of endothelial adhesion molecules was
evaluated and compared with that of other NO donors. SP/W 5186 and SP/W
3672 inhibited the adhesion of U937 monocytes to cultured human
endothelial cells more potently than
S-nitrosoglutathione (GSNO) or spermine NONOate, whereas
nitroglycerin and isosorbide dinitrate were ineffective at comparable
concentrations. A similar rank order of potency was found for the
inhibition of expression of the adhesion molecules vascular cell
adhesion molecule-1, intercellular adhesion molecule-1, and
E-selectin as well as for major histocompatibility complex class II
antigen expression. Estimated IC50 values for vascular cell
adhesion molecule-1were >400 µM for SP/W 4744 (control for SP/W 3672 lacking the cysteine moiety), 200 µM for GSNO and spermine NONOate,
80 µM for SP/W 3672, and 50 µM for SP/W 5186. Moreover, SP/W 5186 inhibited VCAM-1 mRNA levels more potently than GSNO. This effect was
likely to be transcriptional because mRNA degradation was not affected.
In conclusion, SP/W 3672 and SP/W 5186 are novel potent inhibitors of
endothelial activation, and this effect appears to relate to their
ability to liberate NO for prolonged periods of time, either
spontaneously or after conversion to active hydrolytic products.
This article has been cited by other articles:
![]() |
J.-P. Bin, A. Doctor, J. Lindner, E. M. Hendersen, D. E. Le, H. Leong-Poi, N. G. Fisher, J. Christiansen, and S. Kaul Effects of Nitroglycerin on Erythrocyte Rheology and Oxygen Unloading: Novel Role of S-Nitrosohemoglobin in Relieving Myocardial Ischemia Circulation, May 30, 2006; 113(21): 2502 - 2508. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Kim, S. J. Son, E. K. Kim, S. N. Kim, D. G. Yoo, H. S. Kim, S. W. Ryoo, S. D. Lee, K. Irani, and B. H. Jeon Apurinic/apyrimidinic endonuclease1/redox factor-1 inhibits monocyte adhesion in endothelial cells Cardiovasc Res, February 1, 2006; 69(2): 520 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Braam, R. de Roos, H. Bluyssen, P. Kemmeren, F. Holstege, J. A. Joles, and H. Koomans Nitric Oxide-Dependent and Nitric Oxide-Independent Transcriptional Responses to High Shear Stress in Endothelial Cells Hypertension, April 1, 2005; 45(4): 672 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Braam, R. de Roos, A. Dijk, P. Boer, J. A. Post, P. P. C. W. Kemmeren, F. C. P. Holstege, H. A. R. Bluysen, and H. A. Koomans Nitric oxide donor induces temporal and dose-dependent reduction of gene expression in human endothelial cells Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1977 - H1986. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fiorucci, E. Distrutti, A. Mencarelli, G. Rizzo, A. R. D. Lorenzo, M. Baldoni, P. del Soldato, A. Morelli, and J. L. Wallace Cooperation between Aspirin-Triggered Lipoxin and Nitric Oxide (NO) Mediates Antiadhesive Properties of 2-(Acetyloxy)benzoic Acid 3-(Nitrooxymethyl)phenyl Ester (NCX-4016) (NO-Aspirin) on Neutrophil-Endothelial Cell Adherence J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1174 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. De Caterina and C. Manes Inflammation in early atherogenesis: impact of ACE inhibition Eur. Heart J. Suppl., January 1, 2003; 5(suppl_A): A15 - A24. [Abstract] [PDF] |
||||
![]() |
R. A. Skidgel, X.-p. Gao, V. Brovkovych, A. Rahman, D. Jho, S. Predescu, T. J. Standiford, and A. B. Malik Nitric Oxide Stimulates Macrophage Inflammatory Protein-2 Expression in Sepsis J. Immunol., August 15, 2002; 169(4): 2093 - 2101. [Abstract] [Full Text] [PDF] |
||||